SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Shasun

Strides Shasun

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 06, 15:23
1106.50
1.9 (0.17%)
VOLUME 28,566
LIVE
NSE
May 06, 15:23
1106.10
5.15 (0.47%)
VOLUME 165,288
News on Strides Shasun
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy L&T, Strides Shasun, Future Retail: Ashwani Gujral 

1.11 pm | 03 May 2016 |  Source: NEWS18.com

Ashwani Gujral of ashwanigujral.com recommends buying Larsen and Toubro, Strides Shasun and Future Retail and feels that Aurobindo Pharma may test Rs ...

Buy Karnataka Bank, JSW Steel; Wockhardt may hit Rs 1150: Gujral 

1.16 pm | 18 Apr 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com recommends buying Karnataka Bank and JSW Steel and feels that Wockhardt may test Rs 1150....

SP Tulsian: Stocks, sectors you should buy now 

10.17 pm | 13 Apr 2016 |  Source: CNBC-TV18

In an interview with CNBC-TV18, market analyst SP Tulsian spoke about his outlook on the stock market and discussed stock and sector strategies....

Buy Bharat Forge, Ambuja Cements, Strides Shasun: Ashwani Gujral 

3.27 pm | 13 Apr 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one can buy Bharat Forge, Ambuja Cements and Strides Shasun....

Buy Jain Irrigation, midcap pharma, Rel Cap, Rel Infra: Gujral 

12.45 pm | 12 Apr 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com recommends buying Jain Irrigation Systems, midcap pharma, Reliance Capital and Reliance Infrastructure....

Sell BOI, Strides Arcolab, IRB Infrastructure: Sudarshan Sukhani 

10.02 am | 11 Apr 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Bank of India, Strides Arcolab and IRB Infrastructure....

Geneva-based fund not to order drug from Ipca, stock cracks 14% 

9.53 am | 08 Apr 2016 |  Source: Moneycontrol.com

Ipca received warning letter from USFDA for its Ratlam (Madhya Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa) manufacturing units....

Stocks in news: Strides, Bharti, JSPL, Motilal Oswal, IFCI, NTPC

8.02 am | 05 Apr 2016 |  Source: CNBC-TV18

Strides Shasun | Bharti Airtel | Idea Cellular | Jyoti Structures | NTPC | Gallant Ispat | Ricoh India | IFCI | JSPL and Motilal Oswal are stocks, whi...

Strides Shasun acquires 3 brands of Sweden's Moberg Pharma

5.46 pm | 04 Apr 2016 |  Source: PTI

A regulatory filing by Strides Shasun in March had said, the company's wholly-owned subsidiary Strides Pharma Inc has entered into an agreement with M...

Buy Oberoi Realty, Strides Shasun, Ceat: Ashwani Gujral 

12.04 pm | 31 Mar 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one can buy Oberoi Realty, Strides Shasun and Ceat....

Aim to grow biz at 20-25% CAGR: Strides Shasun 

9.40 am | 09 Feb 2016 |  Source: CNBC-TV18

The growth trajectory is very strong going forward and the company has all the necessary engines to grow the business at 20-25 percent CAGR, said Arun...

Strides Shasun consolidated Dec '15 sales at Rs 1,514.57 crore

9.06 am | 09 Feb 2016 |  Source: Moneycontrol.com

Strides Shasun has reported a consolidated total income from operations of Rs 1,514.57 crore and a net profit of Rs 51.86 crore for the quarter ended ...

Buy Strides Arcolab; target of Rs 1570:Religare

3.49 pm | 17 Dec 2015 |  Source: Moneycontrol.com

Religare is bullish on Strides Arcolab and has recommended buy rating on the stock with a target price of Rs 1570 in its research report dated Decembe...

1 2 3 4
Quick Links for Strides Shasun
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.